InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: None

Wednesday, 11/22/2017 10:52:46 AM

Wednesday, November 22, 2017 10:52:46 AM

Post# of 48316
Hard to believe 10 billion dollars worth of valuation on Incyte is due to an unapproved drug that posts similar results to Oncosec results from SITC and Oncosec is valued at only 70 million market cap. If Oncosec were valued equally it would be worth around 200 bucks a share. Risk reward here is incredible.